OKYO
OKYO Pharma
OKYO
OKYO
7 hedge funds and large institutions have $1.54M invested in OKYO Pharma in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Barclays
London,
United Kingdom
|
+$1.3M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$61.9K |
| 3 |
Morgan Stanley
New York
|
+$24.5K |
| 4 |
Cerity Partners
New York
|
+$21.8K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$29.5K |
| 2 |
Renaissance Technologies
New York
|
-$8.09K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$176 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Barclays
London,
United Kingdom
| $1.34M | +$1.3M | +733,333 | +2,933% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $61.9K | +$61.9K | +34,784 | New |
|
|
3
Morgan Stanley
New York
| $49K | +$24.5K | +13,846 | +100% |
|
|
4
Cerity Partners
New York
| $21.8K | +$21.8K | +12,312 | New |
|
5
Geode Capital Management
Boston,
Massachusetts
| $21.5K | – | – | – |
|
|
6
Renaissance Technologies
New York
| $21K | -$8.09K | -4,547 | -28% |
|
7
HSBC Holdings
London,
United Kingdom
| $20.3K | – | – | – |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$29.5K | -15,943 | Closed |
|
|
9
UBS Group
Zurich,
Switzerland
| – | -$176 | -95 | Closed |
|